http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102099159-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2016-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102099159-B1 |
| titleOfInvention | Acrylic acid derivatives, methods for their preparation and methods of use in medicine |
| abstract | The present invention is an acrylic acid derivative as represented by the general formula (I), a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, a preparation method thereof, a pharmaceutical composition containing the same, and a therapeutic agent, particularly a selective estrogen receptor degrading agent (SERD) As regards its use as), the substituents of the general formula (I) are as defined in the detailed description of the present invention. |
| priorityDate | 2015-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 270.